Back
Corporate News
Fabino Enterprises Limited to review financial results at rescheduled board meeting
06-Nov-2026, 04:52
Fabino Enterprises Limited, formerly known as Fabino Life Sciences Limited, has rescheduled a board meeting for Thursday, November 12, 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the half year ended September 30, 2026, along with a limited review report, according to a regulatory filing with the BSE Limited. The trading window will reopen 48 hours after the financial results are declared to the stock exchanges.
